ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc (INM)

3,15
0,02
( 0,64% )
Aktualisiert: 21:00:41

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,15
Gebot
3,14
Fragen
3,22
Volumen
123.831
3,13 Tagesbereich 3,50
2,414 52-Wochen-Bereich 15,576
Marktkapitalisierung
Handelsende
3,13
Handelsbeginn
3,16
Letzte Trade
15
@
3.18
Letzter Handelszeitpunkt
21:01:34
Finanzvolumen
US$ 405.994
VWAP
3,2786
Durchschnittliches Volumen (3 Mio.)
538.720
Ausgegebene Aktien
667.672
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,28
Gewinn pro Aktie (EPS)
-11,5
Erlöse
4,6M
Nettogewinn
-7,68M

Über InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, derm... InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Security Systems Service
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2014
InMed Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker INM. The last closing price for InMed Pharmaceuticals was US$3,13. Over the last year, InMed Pharmaceuticals shares have traded in a share price range of US$ 2,414 to US$ 15,576.

InMed Pharmaceuticals currently has 667.672 shares in issue. The market capitalisation of InMed Pharmaceuticals is US$2,09 million. InMed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.28.

INM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.58-15.54959785523.733.82.861138333.15427233CS
4-1.7-35.05154639184.858.272.8616191204.97105172CS
12-1.99-38.71595330745.148.272.865387204.9546779CS
260.051.612903225813.115.5762.41435523897.94921649CS
52-4.05-56.257.215.5762.41422243727.48796353CS
156-20.45-86.652542372923.63902.414119812531.89858969CS
260-70.85-95.7432432432743902.414106210234.00504442CS

INM - Frequently Asked Questions (FAQ)

What is the current InMed Pharmaceuticals share price?
The current share price of InMed Pharmaceuticals is US$ 3,15
How many InMed Pharmaceuticals shares are in issue?
InMed Pharmaceuticals has 667.672 shares in issue
What is the market cap of InMed Pharmaceuticals?
The market capitalisation of InMed Pharmaceuticals is USD 2,09M
What is the 1 year trading range for InMed Pharmaceuticals share price?
InMed Pharmaceuticals has traded in the range of US$ 2,414 to US$ 15,576 during the past year
What is the PE ratio of InMed Pharmaceuticals?
The price to earnings ratio of InMed Pharmaceuticals is -0,28
What is the cash to sales ratio of InMed Pharmaceuticals?
The cash to sales ratio of InMed Pharmaceuticals is 0,46
What is the reporting currency for InMed Pharmaceuticals?
InMed Pharmaceuticals reports financial results in USD
What is the latest annual turnover for InMed Pharmaceuticals?
The latest annual turnover of InMed Pharmaceuticals is USD 4,6M
What is the latest annual profit for InMed Pharmaceuticals?
The latest annual profit of InMed Pharmaceuticals is USD -7,68M
What is the registered address of InMed Pharmaceuticals?
The registered address for InMed Pharmaceuticals is 340 - 200 GRANVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6C 1S4
What is the InMed Pharmaceuticals website address?
The website address for InMed Pharmaceuticals is www.inmedpharma.com
Which industry sector does InMed Pharmaceuticals operate in?
InMed Pharmaceuticals operates in the SECURITY SYSTEMS SERVICE sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RFACURF Acquisition Corporation
US$ 10,1964
(97,60%)
10,49k
RFACRF Acquisition Corporation
US$ 10,605
(76,46%)
958,23k
ACBAurora Cannabis Inc
US$ 5,425
(47,42%)
65,39M
RNAZTransCode Therapeutics Inc
US$ 8,88
(44,16%)
16,49M
ASSTAsset Entities Inc
US$ 0,7722
(40,58%)
165,2M
VLCNVolcon Inc
US$ 1,85
(-42,19%)
3,47M
CSAICloudastructure Inc
US$ 8,725
(-32,78%)
204,93k
UPCUniverse Pharmaceuticals Inc
US$ 0,1844
(-31,68%)
30,32M
TCBPTC BioPharm Holdings PLC
US$ 0,2464
(-31,56%)
1,76M
CAPTCaptiVision Inc
US$ 0,724
(-31,05%)
7,86M
CYNCYNGN Inc
US$ 0,0865
(21,83%)
427,05M
RIMEAlgorhythm Holdings Inc
US$ 0,0211
(-13,52%)
215,76M
NVDANVIDIA Corporation
US$ 123,8086
(4,35%)
200,36M
ASSTAsset Entities Inc
US$ 0,7722
(40,58%)
165,2M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0538
(22,83%)
121,53M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock